View in EDS HTML Full Text PDF Full Text

Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States.

Saved in:
Bibliographic Details
Title: Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States.
Authors: Fisher, Shelby S.1 (AUTHOR), Lindaas, Arnstein2 (AUTHOR), Muthuri, Stella G.3 (AUTHOR), Lloyd, Patricia C.4 (AUTHOR), Gruber, Joann F.4 (AUTHOR), Richey, Morgan M.5 (AUTHOR), Lyu, Hai2 (AUTHOR), Cheng, Angela S.2 (AUTHOR), Kowarski, Lisa S.3 (AUTHOR), McKillop, Mollie M.3 (AUTHOR), Bui, Christine5 (AUTHOR), Clarke, Tainya C.4 (AUTHOR), Beers, Jeffrey3 (AUTHOR), Burrell, Timothy3 (AUTHOR), Duenas, Pablo Freyria2 (AUTHOR), Chen, Yangping2 (AUTHOR), Sheng, Minya3 (AUTHOR), Forshee, Richard A.4 (AUTHOR), Anderson, Steven A.4 (AUTHOR), Chillarige, Yoganand2 (AUTHOR)
Source: PLoS ONE. 11/24/2025, Vol. 20 Issue 11, p1-18. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0333704